Biocon Ranked at No 2 and Syngene at No 5
“Having forged strategic partnerships with the Mylan and BMS to consolidate its key insulin business, Biocon emerged even stronger in 2012” - Kiran Mazumdar-Shaw, Chairman and Managing Director
Biocon Ranked at No 2 and Syngene at No 5
“Having forged strategic partnerships with the Mylan and BMS to consolidate its key insulin business, Biocon emerged even stronger in 2012” - Kiran Mazumdar-Shaw, Chairman and Managing Director
Biocon Ranked at No 2 and Syngene at No 5
“Having forged strategic partnerships with the Mylan and BMS to consolidate its key insulin business, Biocon emerged even stronger in 2012” - Kiran Mazumdar-Shaw, Chairman and Managing Director